Table 2. Changes in gait-related measurements and TUG time.
| Measures | Change values | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Treatment | Control | |||||||||||||||||
| BLa | INT1 | INT2 | INT3 | INT4 | OSV1 | OSV2 | OSV3 | OSV4 | BLa | INT1 | INT2 | INT3 | INT4 | OSV1 | OSV2 | OSV3 | OSV4 | |
| Gait speed (m/s)* | 0.00 | 0.08 | 0.10 | 0.19 | 0.21 | 0.23 | 0.19 | 0.22 | 0.20 | 0.00 | 0.02 | 0.04 | 0.01 | 0.01 | 0.04 | 0.05 | 0.07 | 0.03 |
| (0.09) | (0.12) | (0.18) | (0.21) | (0.20) | (0.20) | (0.18) | (0.18) | (0.07) | (0.06) | (0.06) | (0.08) | (0.06) | (0.08) | (0.08) | (0.08) | |||
| Cadence (steps/m) | 0.00 | 3.86 | 4.71 | 10.50 | 11.39 | 14.82 | 12.03 | 11.36 | 14.03 | 0.00 | 2.62 | 5.00 | 0.99 | 0.93 | 7.76 | 1.01 | 5.75 | 4.03 |
| (8.30) | (8.30) | (12.30) | (18.10) | (13.80) | (14.40) | (10.20) | (12.40) | (10.00) | (8.40) | (6.40) | (6.10) | (6.50) | (6.60) | (6.10) | (7.40) | |||
| Step length (m) | 0.00 | 0.02 | 0.03 | 0.05 | 0.06 | 0.05 | 0.04 | 0.06 | 0.04 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.03 | 0.02 | 0.00 |
| (0.05) | (0.04) | (0.05) | (0.06) | (0.05) | (0.05) | (0.05) | (0.05) | (0.02) | (0.02) | (0.03) | (0.04) | (0.04) | (0.04) | (0.04) | (0.03) | |||
| TUG (s) | 0.00 | −1.14 | −0.65 | −0.50 | −0.70 | −2.68 | −1.99 | −1.79 | −2.33 | 0.00 | −0.49 | −0.93 | −1.05 | −0.91 | −1.55 | −2.62 | −1.16 | −1.77 |
| (0.93) | (1.59) | (2.58) | (1.68) | (2.44) | (1.09) | (1.18) | (3.05) | (2.72) | (1.40) | (1.87) | (1.16) | (1.60) | (1.86) | (1.66) | (2.69) | |||
Values are means (1SD). *p for interaction < 0.05, two-way repeated ANOVA. Bla, average of base line phase; INT, intervention (or nonintervention) phase; OSV, observation phase; TUG, timed Up and Go test.